Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Published April 13, 2022 · Recall initiated: March 11, 2022
Summary
FDA records drug Class II recall D-0749-2022, published April 13, 2022 and initiated March 11, 2022. Recalling firm: DASH Pharmaceuticals LLC; Status: Terminated; Reported quantity: 45,940 Unit Dose Cups; Lot: Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-Up
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- DASH Pharmaceuticals LLC
- Distributor
- Nationwide within the United States
- Lot
- Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATravoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan PharmaceuticalsApril 13, 2022
- FDAThe Natural Dentist Healthy Breath Antiseptic Rinse, Cool Mint, 16.9 FL OZ (500 mL, Manufactured for ReviveApril 13, 2022
- FDANETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit contains Vial 1 (ReactionApril 13, 2022
- FDAMethylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant CadistaApril 13, 2022
- FDAJanumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles perApril 13, 2022
- FDAOrphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc.,April 13, 2022
Questions about this recall
Was Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458. recalled?
Yes. FDA published recall D-0749-2022 on April 13, 2022. Reported hazard: Labeling: Label Mix-Up
What should I do if I have this product?
Voluntary: Firm initiated · Letter